title: Xpert® MTB/RIF for extra-pulmonary tuberculosis: time to look beyond accuracy.
authors.affiliation: Department of Epidemiology & Biostatistics, McGill University, Montreal, QC Canada; McGill International TB Centre and McGill Global Health Programs, Montreal, QC Canada.
authors.forename: Samuel G
authors.initials: SG
authors.lastname: Schumacher
authors.affiliation: <sup>*</sup>Department of Epidemiology & Biostatistics, McGill University, Montreal, QC Canada; McGill International TB Centre and McGill Global Health Programs, Montreal, QC Canada. madhukar.pai@mcgill.ca.
authors.forename: Madhukar
authors.initials: M
authors.lastname: Pai
mesh_terms: D000904:Antibiotics, Antitubercular / Q000494:pharmacology*; D024901:Drug Resistance, Multiple, Bacterial; D005260:Female; D006801:Humans; D008297:Male; D012293:Rifampin / Q000494:pharmacology*; D014397:Tuberculosis, Pulmonary / Q000175:diagnosis*
chemical_list: D000904:Antibiotics, Antitubercular; D012293:Rifampin